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ABSTRACT
Background: Chrysophyllum albidum (C. albidum) is used in folklore 
for the treatment of diabetes. The present study was designed to 
investigate the effect of the ethanolic extract of Chrysophyllum albidum 
stem bark on alloxan-induced diabetic rats. 
Methods: Normal and alloxan-induced diabetic rats were randomly 
divided into groups and treated with ethanolic extract of C. albidum 
stem bark for 7-28 days. Metformin (150mg/kg) was used as the 
standard control. At the end of the treatment, blood sample was 
collected for glucose test, while serum was extracted for triglyceride 
(TG), total cholesterol (TC), low density lipoprotein cholesterol (LDLC), 
and high density lipoprotein (LDLC) evaluation. The pancreas was 
excised and evaluated for superoxide dismutase (SOD), catalase (CAT), 
glutathione (GSH) and malondialdehyde (MDA) and histological 
damage. 
Results: Blood glucose, serum TG, TC, LDL-C levels were significantly 
increased whereas HDL-C levels were significantly (p<0.05) decreased 
in diabetic rats. Also, pancreatic levels of CAT, SOD, GSH were significantly 
increased (p<0.05) whereas MDA levels were significantly (p<0.05) 
decreased in diabetic rats. However, the levels of these parameters were 
restored significantly (p<0.05) in diabetic rats treated with 100, 200 
and 400mg/kg of ethanolic extract of C. albidum stem bark. 
Conclusion: Ethanolic extract of C. albidum stem bark has potentials 
as remedy for diabetes. The findings in the presents study support the 
use of C. albidum in folklore for the treatment of diabetes. 
INTRODUCTION
Hyperglycemia and dyslipidemia, among other 
disorders, are metabolic syndromes associated 
with a dysfunctional endocrine system clinically 
referred to as diabetes mellitus (DM).1 Diabetes 
mellitus (DM) is a common endocrine disorder 
affecting more than 200 million people worldwide. 
The dilapidating action of DM qualifies it as a 
disease of major public health concern and epide-
miological survey showed that it is the seventh 
leading cause of death worldwide.2 Many distinct 
types of DM exist and the etiology being a complex 
interaction of genetics, environmental factors, and 
life-style choices.3 In addition to hyperglycemia 
the metabolic deregulation associated with DM 
causes secondary pathophysiologic changes in 
multiple organ systems that impose a tremendous 
burden on the individual with diabetes and on the 
health care system.4 Diabetes tends to damage cell 
membranes which results in elevated production of 
free radicals. The generation of free radicals appears 
to play a critical role in the pathogenesis of diabetes 
mellitus.5 Orthodox medicines have played vital 
function in the management of diabetes however, 
situations which include toxicities, medication cost 
and treatment failures, created an alternative quest 
for herbal formulation remedies for the alleviation 
and management of DM.6
Herbs are sources of potential therapeutic 
agents against various diseases due to their biodi-
versity and presence of a wide array of bioactive 
phytochemicals and secondary metabolites.7 
Chrysophyllum albidum (C. albidum) is a plant 
used in folklore medicine due to its therapeutic 
values. The bark is used for the treatment of 
yellow fever and malaria, while the leaf is used 
as an emollient and for the treatment of skin 
eruption, stomach ache and diarrhoea.8 The 
leaf and seed cotyledon have been reported to 
possess  anti-hyperglycemic and hypolipidemic 
effects.9 It has antimicrobial,  anti-nociceptive, 
 anti-inflammatory and  anti-oxidant activities. 
It serves as a natural  anti-oxidant booster to 
remove free radicals from oxidative stress asso-
ciated disorders.10 The fleshy pulp of the fruit 
is eaten especially as snacks and its fruit has 
been found to have higher ascorbic acid content 
than oranges and guava.11 Tannins, flavonoids, 
terpenoids, proteins, carbohydrates and resins 
are the phytochemicals that have been reported 
in C. Albidum.12 The stem bark has been used 
for the treatment of diabetes with no scientific 
evidence. Therefore, the present study was 
designed to evaluate the anti-diabetic potentials 
of the ethanolic extract of C. albidum stem bark 
in  alloxan-induced diabetic rats
MATERIALS AND METHOD
Drug and chemicals
Metformin was used as a standard control in the 
study and alloxan monohydrate was used in the 








Ethanolic extract of Chrysophyllum albidum stem 
bark prevents alloxan-induced diabetes 
www.phytomedicine.ejournals.ca Discovery Phytomedicine 2019; 6(2): 26-32. doi: 10.15562/phytomedicine.2019.81 27
Ethanolic extract of Chrysophyllum ... XXX et al.
Plant
Collection and identification of plant material
The stem bark of C. albidum was obtained 
March, 14th 2016 from Obelle town Ikwere Local 
Government Area of Rivers State. It was botanically 
identified by Mr Kola Adeleke of the department of 
Pharmacognosy, Madonna University, Nigeria.
Preparation of plant extract
The stem bark of the tree of C. albidum was oven 
dried at 48 degrees centigrade for 4 days after which 
it was broken down into smaller pieces with the aid 
of a mechanical grinder. 500g of the powder was 
macerated with ethanol (1900ml) for 72 hours with 
constant shaking. The extract was then filtered after 
72 hours and the filtrate concentrated using a rotary 
evaporator. The yield of the extract was found to be 
29.52g which was stored a refrigerator for further 
use.
Phytochemical analysis
The following tests were carried out; test for flavo-
noid, tannin, protein, carbohydrate, saponin, alka-
loid, glycoside, reducing sugar and steroid. The tests 
were carried out based on the procedures outlined 
by Harborne (1998).13
Animal
Adult albino rats (130-150g) were used for this 
study. They were kept in the animal house, of the 
Department of Pharmacology and Toxicology, 
Madonna University, Nigeria. They were allowed 
to acclimatize for 1 week prior to the experiment 
during which they were introduced to growers 
mash. The rats were housed in clean gauzed cages 
having free access to feed and water and maintained 
under standard conditions.
Acute toxicity test 
This was carried out in 2 phases using the modified 
Lorke’s method.14 In phase 1, nine rats divided into 
3 groups containing 3 rats each were used. Each 
group of rats were administered with different doses 
(10,100 and 1000mg/kg) of the plant extract. The 
rats were placed under observation for 24 hours to 
monitor their behavior as well as to see if mortal-
ity would occur. Phase 2 used 3 rats divided into 
3 groups of 1 rat each. The rats were administered 
with 1500, 2500 and 5000 mg/kg of the plant extract 
and observed for 24hrs for changes in behavior and 
mortality. The LD50 which is the square root of the 
highest dose with no mortality multiplied by the 
lowest dose with mortality could not be calculated 
since none of the doses killed the rats although, 
some changes such as sluggish behavior, reduced 
appetite and thirst were observed.
Preparation of diabetic rats
The rats were made diabetic by intravenously inject-
ing of 150mg/kg body weight of alloxan mono-
hydrate dissolved in normal saline.15 Seventy two 
hours after alloxan administration, the induction 
of diabetes was confirmed by measuring the blood 
glucose levels using glucometer. The rats with blood 
glucose levels of 250-500mg/dL were considered 
diabetic and employed for the study.16
Grouping of rats and drug administration
•	 Group	A	contains	45	rats	divided	into	3	groups	
of 15 rats each. Rats were treated with 100, 200 
and 400 mg/kg of C A extract for 7, 21 and 
28 days respectively
•	 Group	B	contains	15	rats	divided	into	3	groups	
of 5 rats and served as non-diabetic control 
treated with 0.2ml of normal saline for 7, 21 
and 28 days respectively, 
•	 Group	C	contains	15	rats	divided	into	3	groups	
of 5 rats which served as diabetic, non-treated 
rats for 7, 14 and 21 days 
•	 Group	D	contains	15	rats	diabetic	rats	divided	
into 3 groups of 5 rats which were treated with 
the standard drug (metformin) for 7, 14 and 
28 days 
•	 Group	D	 contained	 diabetic	 rats	 treated	with	
100, 200 and 400mg/kg body weight of the 
extract for 7, 14 and 28 days respectively while 
Sacrifice of the rats
On the 29th day, the rats were sacrificed under 
anesthesia using diethyl ether and blood was 
collected from the heart. Two milliliter of blood was 
collected into the fluoride oxalate-bottle for  blood 
glucose analysis. Also, 4 mL of blood was collected 
into plain sample bottle for lipid profile evaluation. 
Blood	 glucose	 was	 evaluated	 using	 glucometer	
whereas serum total cholesterol, triglyceride, low 
density lipoprotein cholesterol and high density 
lipoprotein cholesterol as reported using standard 
laboratory test kits (Randox Diagnostics, Crumlin, 
UK). LDL–cholesterol was estimated as reported 
by Friedewald et al., 1972.17 Pancreas was exercised 
rinsed in cold 1.05 % KCL solution the homogenized 
with 0.1M phosphate buffer (pH 7.2). The homoge-
nate was centrifuged at 1200 rpm for 15min and the 
supernatant was decanted and evaluated for oxida-
tive stress markers. Pancreas total protein content 
was determined according to Gonall et  al. 194918 
whereas malondialdehyde (MDA) was assayed as 
reported	by	Buege	and	Aust.19 Reduced glutathione 
(GSH) was evaluated as reported by Sedlak and 
Lindsay 196820 whereas superoxide dismutase (SOD) 
was measured as reported bySun and Zigma 1978.21 
Catalase (CAT) was analyzed using the method of 
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Aebi 198422 whereas Glutathione peroxidase (GPX) 
activity assayed according to Rotruck et al. 1973.23
Statistical analysis
Data are expressed as mean ± SEM and were 
subjected to one way analysis of variance (ANOVA) 
test and Dunnett’s post hoc test. Results were 
considered to be significant at p<0.05
Phytochemical analysis
The phytochemicals present in the stem bark of 
C. albidum are shown in the table below
Table 1  Phytochemicals evaluation of the 












Key : ++= High, += Moderate, - = Absent
Acute toxicity study
Phase one
Table 2  The acute toxicity test (LD-50) 
result of phase 1 using the 
modified Lorkes method (Lorke, 
1983)





Table 3  The acute toxicity test (LD-50) 
result of phase 2 using the 
modified Lorkes method




In phase 1, the rats that were administered 
different doses (10,100 and 1000mg/kg) of the plant 
extract after observation for 24 hours, no death was 
recorded neither were there noticeable behavioural 
changes. In the phase 2, all the rats also survived. 
There were no observable changes in behavior 
except at the highest dose (5000mg/kg) where the 
rat exhibited sluggish movements, lack of appetite 
and thirst although it didn’t die. It therefore indi-
cated that the plant extract has a wide therapeutic 
index. 
RESULTS
Phytochemical evaluation of the ethanolic extract of 
C. albidum stem back shows high presence of flava-
noids, alkaloids and tannins (Table 1). No mortality 
was observed during the evaluation of the LD50 of 
C. albidum (Table 2 and 3). The body weights of 
non- diabetic rats treated with 100-400mg/kg of 
C. albidum extract for 7-28 days were not significantly 
(p<0.05) altered when compared to non-diabetic 
control. However body weights were significantly 
(p<0.05) decreased in diabetic rats when compared 
to control. In contrast body weight was increased 
in a dose and time time dependent manner in 
diabetic rats pretreated with 100-400mg/kg 
of C. albidum extract when compared to diabetic 
control (Table 4). However, increases in body 
weights were most observed in metformin 
treated rats and differ significantly (p<0.05) when 
compared to 100 and 200mg/kg of C. albidum 
extract (Figure 1). 
Furthermore, 100-400mg/kg of C albidum extract 
had no significant (p<0.05) effects on glucose levels 
in non-diabetic rats when compared to non-dia-
betic control (Table 5). On the other hand, glucose 
level was significantly (p<0.05) increased in allox-
an-treated rats when compared to control. More 
diabetic rats administered with 100-400 mg/kg of 
the extract showed significant (p<0.05) decreases in 
blood glucose levels in a dose- dependent manner 
when compared to diabetic control. Comparatively, 
metformin produced significant (p<0.05) reduction 
in blood glucose level than 100, 200 and 400 mg/kg 
of the extract (Table 5). C. albidum extract did not 
produce significant (p<0.05) effects on serum TG, 
TC, LDL and HDL-C levels in non-diabetic rats 
when compared to non- diabetic control (Table 6-9). 
However, diabetic rats showed significant (p<0.05) 
elevations in glucose levels when compared to 
control. Nevertheless, diabetic rats treated with 
100-400mg/kg of C. albidum extract showed 
decreased in serum levels of TG, TC and HDL with 
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increased in LDL-C levels significantly (p<0.05) 
and in a dose-dependent manner (Table 6-9).
Furthermore, pancreatic levels of GSH, CAT, 
SOD and MDA were not significantly (p<0.05) 
altered in non-diabetic rats treated with the extract 
of C. albidum when compared to non-diabetic 
control (Table 7). In sharp contracts, pancreatic 
levels of GSH, CAT, SOD, were increased while 
MDA levels were decreased significantly (p<0.05) 
and in diabetic rats. However, the pancreatic levels 
of GSH, CAT, SOD, and MDA levels were signifi-
cantly (p<0.05) restored and in a dose-dependent 
manner in C. albidum extract treated diabetic rats 
(Table 10). 
DISCUSSION
Diabetes Mellitus (DM) is a metabolic disease associ-
ated with impaired glucose and lipid metabolism. It is 
also associated with impaired beta cell function and 
oxidative stress.24 The management of DM involves 
the use of insulin and oral hypoglycemic agents.25 
However, some herbal preparations contained 
active medicinal constituents which are used in the 
management of diabetes.26 Recently, the world health 
organization estimated that 80% of people worldwide 
rely on herbal medicine for part of their primary 
health care. In Germany, about 600-700 plant based 
medicines are available and are prescribed by some 
70% of German physicians.26 Therefore, the present 
study evaluated the effect of the ethanolic extract of 
C. albidum stem bark on alloxan –induced diabetic 
rats. In the present study, normal rats treated with 
100-400mg/kg of C. albidum extract showed no 
changes in body weights. However, decreases in body 
weights were observed in diabetic rats. Interestingly, 
body weights were restored in diabetic rats treated 
with 100-400mg/kg of C. albidum extract treated. 
This study observed normal blood glucose levels in 
non-diabetic rats treated with 100-400mg/kg of C. 
albidum extract. On the other hand, blood glucose 
levels were elevated in diabetic rats. The observed 
increases in blood glucose levels in diabetic rats were 
restored in rats treated with 100-400mg/kg of C. 
albidum extract. 
Furthermore, lipid profile which is usually 
altered in diabetic condition is a primary factor 
for the development of cardiovascular diseases.27 
In the present study, serum levels of TG, TC, 
LDL-C and HDL-C were normal in rats treated 
with 100-400mg/kg of C. albidum extract. 
However, serum levels of TG, TC, LDL-C, and 
HDL-C were altered in diabetic rats, but were 
restored in diabetic rats treated with 100-400mg/
kg of C. albidum extract. Studies have shown 
that diabetes is associated with oxidative stress 
characterized by altered levels of SOD, CAT, 
GSH, GPX and MDA.28 The by-products of lipid 
Figure 1  Effect of Chrysophyllum albidum on body weight of alloxan-treated 
albino rats
Table 5  Effect of Chrysophyllum albidum on glucose level of 
alloxan-treated albino rats
Dose (mg/kg) 7days (mg/kg) 14days (mg/kg) 28 days (mg/kg)
Control 80.9±7.00 82.4±7.33 80.7±6.45
Diabetic Control (DC) 400.8±3.12 a 389.6±11.7 a 380.1±12.7 a
CA 100 79.1±6.31 77.8±5.42 76.7±6.12
CA 200 77.5±5.43 76.6 ±5.00 74.9±7.53
CA 400 74.7±5.20 74.5±6.51 72.7±6.21
DC +Metformin 150.9±30.1 b 121.6±9.57 b 100.1±9.62 b
DC +CA 100 301.3±3.22 c 250.1±13.6 c 201.8±11.8 c
DC +CA 200 252.7±12.6 d 200.6±11.9 d 150.2±10.3 d
DC +CA 400 201.8±11.6 e 155.4±8.52 e 110.9±10.8 e
CA= Chrysophyllum albidum, DC= Diabetic Control, Values are expressed as Mean± SEM, n=5, 
Values with different super script down the column differ significantly at p<0.05 ANOVA
Table 6  Effect of Chrysophyllum albidum on serum triglyceride level 
of alloxan-treated albino rats
Dose (mg/kg) 7days (mg/kg) 14days (mg/kg) 28 days (mg/kg)
Control 58.I±3.61 57.8±4.32 55.7±3.51
Diabetic Control (DC) 299.9±15.2a 300.5±12.3 a 310.2±11.8 a
CA 100 59.6±4.57 61.9±5.11 58.5±4.21
CA 200 57.6±5.33 60.6±6.32 58.7±5.23
CA 400 60.1±6.63 58.3±5.56 57.4±4.76
DC +Metformin 100.6±9.61 b 99.1±8.90 b 70.9±6.41 b
DC +CA 100 237.4±12.7 c 187.6±11.4 c 120.3±11.5 c
DC +CA 200 160.9±9.32 d 131.8±10.7 d 100.7±10.6 d
DC +CA 400 101.4±11.6 a  73.3±7.33 e 60.8±7.55 e
CA= Chrysophyllum albidum, DC= Diabetic Control, Values are expressed as Mean± SEM, n=5, 
Values with different super script down the column differ significantly at p<0.05 ANOVA
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peroxidation such as conjugated dienes and MDA 
are increased in patients with obesity, metabolic 
syndrome and DM.29 In the current study, there 
were no effects observed on pancreatic levels of 
SOD, GSH, CAT, GPX and MDA in normal rats 
treated with 100-400mg/kg of C. albidum extract. 
Nevertheless, pancreatic levels of SOD, GSH, 
CAT, GPX and MDA were altered in diabetic rats. 
However, pancreatic levels of SOD, GSH, CAT, 
GPX and MDA were restored in 100 - 400mg/kg of 
C. albidum extract treated diabetic rats. 
Alloxan, a β-cytotoxic toxic glucose analogue 
is commonly used for the development of animal 
model of type-I diabetes mellitus (IDDM). Alloxan 
is rapidly taken up by the pancreatic β-cells through 
GLUT2 receptors.30 The observed increases in 
glucose levels of diabetic rats could be attributed 
to alloxan selective inhibition of glucose-induced 
insulin secretion through specific inhibition of 
glucokinase, the glucose sensor of the beta cell, and 
its ability to induce free radical formation, resulting 
in the selective necrosis of beta cells. Furthermore, 
this study observed decreases in glucose levels in 
diabetic rats treated with metformin. Metformin 
is a standard drug used for the treatment of diabe-
tes. The exact molecular mechanism of its action 
remains unknown. However, studies have shown 
that it can inhibits liver gluconeogenesis, facilitates 
glucose uptake into peripheral tissues, such as stri-
ated muscle and acts in the gut also, it increases 
insulin sensitivity.31 In this study, the extract of C. 
albidum might have exhibits similar mechanism as 
metformin in decreasing glucose levels in treated 
diabetic rats. Also, the effects of C. albidum extract 
could be attributed to its ability to increase insulin 
production by pancreatic cells. Also C. albidum 
extract might have decrease the release of gluca-
gon or stimulates direct glycolysis in peripheral 
tissues or reduces glucose absorption from the 
gastrointestinal tract.32 C. albidum extract contains 
phytochemicals which include terpenoids that are 
known to reduce glycaemia through many mecha-
nisms which include insulin like activity, inhibition 
of gluconeogenesis and glycogenolysis.33 The alter-
ations in pancreatic levels of GSH, CAT, SOD, and 
MDA are signs of oxidative stress and lipid peroxi-
dation via the generation of free radicals. Therefore, 
the effects of C. albidum extract observed on 
GSH, CAT, SOD, and MDA in diabetic rats could 
be attributed to its antioxidant effect through the 
inhibition of free radical production and its abil-
ity to regenerate antioxidants. C. albidum extract 
contains flavonoids, tannins and phenolics which 
have antioxidant activities. Studies have also shown 
that C albidum extract contains high ascorbic acid 
contents which might have contributed to its anti-
oxidant effect observed in the present study. These 
phytochemicals might have protected pancreas 
beta cells against oxidative stress, by increasing the 
endogenous defensive capacity of the pancreas to 
combat oxidative stress and by direct scavenging of 
free radicals.34 
Table 7  Effect of Chrysophyllum albidum on total cholesterol level 
of alloxan-treated albino rats
Dose (mg/kg) 7days (mg/kg) 14days (mg/kg) 28 days (mg/kg)
Control 90.0±7.32 91.8±8.33 89.6±8.45
Diabetic Control (DC) 355.9±12.1 a 360.2±13.7 a 377.9±13.0 a
CA 100 91.8±7.00 90.2±7.31 87.5±8.90
CA 200 92.0±7.52 88.4±8.62 86.0±7.57
CA 400 90.9±8.61 86.9±7.52 84.9±6.31
DC +Metformin 120.7±11.0 b 110.0±11.3 b 90.7±28.32 b
DC +CA 100 257.8±12.7 c 209.7±13.8 c 159.3±10.37 c
DC +CA 200 200.0±12.0 d 150.4±11.0 d 120.4±10.6 d
DC +CA 400 155.6±10.6 e 130.8±10.8 a 90.9±7.52 e
CA= Chrysophyllum albidum, DC= Diabetic Control, Values are expressed as Mean± SEM, n=5, 
Values with different super script down the column differ significantly at p<0.05 ANOVA
Table 8  Effect of Chrysophyllum albidum on high density 
lipoprotein cholesterol level of alloxan-treated albino rats
Dose (mg/kg) 7days (mg/kg) 14days (mg/kg) 28 days (mg/kg)
Control 42.3±3.32 43.4±3.12 44.6±4.42
Diabetic Control (DC) 10.7±0.27 a 11.9±0.77 a 13.4±0.98 a
CA 100 42.1±3.22 40.1±3.60 40.6±3.70
CA 200 43.8±3.71 40.9±4.21 42.8±3.51
CA 400 43.7±3.60 41.6±3.33 41.9±3.42
DC +Metformin 30.0±2.75 b 37.7±3.71 b 40.3±3.56 b
DC +CA 100 15.5±1.20 c 22.0±1.22 c 27.5±3.33 c
DC +CA 200 21.7±2.30 d 27.5±2.60 d 34.1±3.71 d
DC +CA 400 27.0±2.55 b 32.0±3.50 e 42.9±4.57 b
CA= Chrysophyllum albidum, DC= Diabetic Control, Values are expressed as Mean± SEM, n=5, 
Values with different super script down the column differ significantly at p<0.05 ANOVA
Table 9  Effect of Chrysophyllum albidum on low density lipoprotein 
cholesterol level of alloxan-treated albino rats
Dose (mg/kg) 7days (mg/kg) 14days (mg/kg) 28 days (mg/kg)
Control 36.7±2.33 37.4±2.11 32.0±2.03
Diabetic Control (DC) 229.9±9.88 a 288.9±10.1 a 302.6±10.3 a
CA 100 38.6±2.00 38.6±3.90 35.6±2.70
CA 200 37.9±2.33 35.4±3.10 31.9±3.62
CA 400 35.4±2.41 34.7±2.51 32.6±3.11
DC +Metformin 70.9±5.29 b 52.5±3.40 b 36.8± 3.51b
DC +CA 100 195.5±9.88 c 142.0±8.61 c 140.7±7.66 c
DC +CA 200 146.3±7.00 d 97.8 ±5.44d 66.5±5.43 d
DC +CA 400 108.8±7.90 b 84.5±6.33 a 50.9±4.33 e
CA= Chrysophyllum albidum, DC= Diabetic Control, Values are expressed as Mean± SEM, n=5, 
Values with different super script down the column differ significantly at p<0.05 ANOVA
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Conclusion: The oral administration of the 
ethanolic extract of Chrysophyllum albidum 
stem back demonstrated anti-hyperglycemic, 
 anti-hyperlipidemic and anti-oxidative effects on 
 alloxan-induced diabetic rats. The present study, 
hypothesize that ethanolic extract of Chrysophyllum 
albidum contains essential medicinal substances 
that could be used as remedy for diabetes. However, 
further investigation to isolate the active medicinal 
substances and elucidate the exact mechanism of 
action is very imperative.
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